'IV NAD+ is far superior to pills and worth the cost'

A claim-check on NAD+ IV-drip marketing. Verdict: misleading.

What was said

Common in NAD+ clinic marketing: IV NAD+ is far more effective than oral precursors — "100% bioavailable" and worth the high per-session cost — for energy, recovery, and anti-aging S1.

What the record shows

• There are no rigorous randomized trials showing IV NAD+ delivers anti-aging or wellness benefits, and no standardized protocol or long-term safety data S1.
• Bioavailability claims are contested; getting a substance into the bloodstream is not the same as it producing a proven clinical benefit over cheaper oral precursors S1S2.
• IV NAD+ commonly causes flushing and nausea during infusion and costs hundreds to thousands of dollars per session S1.

Reconciliation

The claim is misleading: it dresses an infusion-route talking point ("100% bioavailable") as proof of superior benefit, when the outcome evidence for IV NAD+ simply isn't there. "Delivered directly" is not "shown to work better" S1S2.

What would change this verdict

Head-to-head randomized trials showing IV NAD+ produces a clinically meaningful benefit over oral precursors, with a safety and dosing standard — which do not currently exist S1S2.